Kramer Levin client Finjan won a patent infringement trial against Blue Coat Systems on August 4, when a California jury returned a verdict of infringement of five Finjan patents. Nasdaq-listed Finjan, a computer and network security company, had alleged infringement by Blue Coat Systems products WebPulse, ProxySG, CAS (or Content Analysis System), MAA (or Malware Analysis Appliance) and ProxyAV. Following a two-week jury trial in San Jose, CA, before the Honorable Beth Labson Freeman of the U.S. District Court for the Northern District of California, the jury returned a unanimous verdict that Blue Coat had literally infringed four Finjan patents and had infringed a fifth patent under the doctrine of equivalents. The jury awarded Finjan $39.5 million in compensatory damages.
The Finjan team was led by partners Paul J. Andre, Lisa Kobialka and James Hannah and included associates Hannah Lee, Kristopher B. Kastens, Michael H. Lee, Benu Mehra Wells, Aakash Jariwala, Cristina Martinez, Austin Manes, Nobumasa Hiroi and Yuridia Caire.
The verdict against Blue Coat is the latest in a series of wins by Kramer Levin’s IP Department, which, in the last ten months, has won five cases in federal district court (including two jury verdicts, one bench verdict and two settlements on the cusp of favorable verdicts) and five Inter Partes Review trials in the U.S. Patent Office on behalf of clients Finjan, Prism, Merck, MRC Global and Depomed.